Altavista Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $3.43M | Buy |
22,454
+1,218
| +6% | +$186K | 0.69% | 37 |
|
|
2021
Q3 | $3.43M | Sell |
21,236
-103
| -0.5% | -$16.7K | 0.76% | 35 |
|
|
2021
Q2 | $3.49M | Buy |
21,339
+1,723
| +9% | +$282K | 0.76% | 37 |
|
|
2021
Q1 | $2.95M | Sell |
19,616
-74
| -0.4% | -$11.1K | 0.72% | 37 |
|
|
2020
Q4 | $2.98M | Sell |
19,690
-146
| -0.7% | -$22.1K | 0.76% | 34 |
|
|
2020
Q3 | $2.69M | Sell |
19,836
-816
| -4% | -$110K | 0.74% | 37 |
|
|
2020
Q2 | $2.82M | Sell |
20,652
-92
| -0.4% | -$12.6K | 0.82% | 35 |
|
|
2020
Q1 | $2.24M | Buy |
20,744
+603
| +3% | +$65K | 0.76% | 34 |
|
|
2019
Q4 | $2.43M | Sell |
20,141
-2,763
| -12% | -$333K | 0.72% | 38 |
|
|
2019
Q3 | $2.28M | Buy |
22,904
+481
| +2% | +$47.9K | 0.71% | 39 |
|
|
2019
Q2 | $2.45M | Buy |
22,423
+128
| +0.6% | +$14K | 0.78% | 36 |
|
|
2019
Q1 | $2.49M | Buy |
22,295
+171
| +0.8% | +$19.1K | 0.88% | 35 |
|
|
2018
Q4 | $2.13M | Buy |
22,124
+869
| +4% | +$83.8K | 0.87% | 38 |
|
|
2018
Q3 | $2.59M | Sell |
21,255
-132
| -0.6% | -$16.1K | 0.96% | 34 |
|
|
2018
Q2 | $2.35M | Sell |
21,387
-183
| -0.8% | -$20.1K | 0.94% | 34 |
|
|
2018
Q1 | $2.3M | Buy |
21,570
+2,540
| +13% | +$271K | 0.97% | 32 |
|
|
2017
Q4 | $2.03M | Buy |
19,030
+247
| +1% | +$26.4K | 0.86% | 38 |
|
|
2017
Q3 | $2.09M | Buy |
18,783
+429
| +2% | +$47.7K | 0.99% | 33 |
|
|
2017
Q2 | $1.9M | Buy |
18,354
+1,395
| +8% | +$144K | 0.94% | 36 |
|
|
2017
Q1 | $1.66M | Buy |
16,959
+2,922
| +21% | +$286K | 0.83% | 39 |
|
|
2016
Q4 | $1.24M | Buy |
14,037
+1,818
| +15% | +$161K | 0.67% | 43 |
|
|
2016
Q3 | $1.18M | Buy |
+12,219
| New | +$1.18M | 0.64% | 43 |
|